Broad-Spectrum Inhibition of Respiratory Virus Infection by MicroRNA Mimics Targeting p38 MAPK Signaling
The majority of antiviral therapeutics target conserved viral proteins, however, this approach confers selective pressure on the virus and increases the probability of antiviral drug resistance. An alternative therapeutic strategy is to target the host-encoded factors that are required for virus inf...
Main Authors: | Jana L. McCaskill, Sarah Ressel, Andreas Alber, Jane Redford, Ultan F. Power, Jürgen Schwarze, Bernadette M. Dutia, Amy H. Buck |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253117301488 |
Similar Items
-
Antiviral microRNA expression signatures are altered in subacute sclerosing panencephalitis
by: Kemal Ugur Tufekci, et al.
Published: (2021-01-01) -
Research advances in microRNAs in regulating hepatitis C virus replication and antiviral therapy
by: CUI Xianghua
Published: (2015-05-01) -
Serum microRNAs predict response of patients with chronic hepatitis B to antiviral therapy
by: Bingqin Tan, et al.
Published: (2021-07-01) -
Design of Effective Primary MicroRNA Mimics With Different Basal Stem Conformations
by: Fiona T van den Berg, et al.
Published: (2016-01-01) -
The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy
by: Shudong Wang, et al.
Published: (2016-06-01)